| Tag | Content |
|---|
EnhancerAtlas ID | HS016-00754 |
Organism | Homo sapiens |
Tissue/cell | CD14+ |
Coordinate | chr6:138167300-138169320 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr6:138167438-138167450 | AAATAAACAATC | - | 6.62 | | Nr5a2 | MA0505.1 | chr6:138167866-138167881 | GTTGACCTTGAGTTC | - | 6.07 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_46070 | chr6:138168705-138172271 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr6 | 138167600 | 138168446 | | chr6 | 138167673 | 138168756 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH06I137846 | chr6 | 138167174 | 138172257 |
|
Enhancer Sequence | AGAAGACTCC CGGGTTCGTG GCATGGGGAA ATCAAGGATG GAGTGCCCAT CCCTAAGATA 60
GAAAACAAAT GTAGAGGGGG AACCTAGTTG GGAGTTAGGA TGATAAAGTT TGAAATGTAA 120
AAGTGGTTAA GAGGAATGAA ATAAACAATC AATCATAAGT GGTTATCAAA TGGTACGAGG 180
GTCAAGTTGA AGTTAGCCGC ATGAATCAGT AGTAACATCA CCAGGAGGTG ACCTAAGCTT 240
CCCAGCAGAG CTTAGGAGTG AAGCAGAGAA AACAGGTTCA TCTTTCCTCT AGAGCAAAGT 300
GCGGGAATGT GAGAGTGGTA GAAGGTCAAG CAGAAAGAGA ACTATCAGGC ACCAGTGACG 360
GTGCAGCTCA ATGTCACTGA GCTTGAGCTC TGTGCCAGGA TAGATGAGGA GCCAGAGGAA 420
AGCCTAGTAA AGAGTTCCGG GACAGTGAAG GGAACAGAAG GTGTTTCTGA GGTCAAACAG 480
AAGTTCAGTG GGAGACGTAG GGATAAGTGG CTATGGTCAG GATAGAGAAT CGCAACATGT 540
AGGATGCCAG AGGTAGAGTG CTTTCAGTTG ACCTTGAGTT CTAAGATGTG GCTGTGCTCC 600
AAGGGGGCTA CTTGCACTAA TGTGGCTCGG GTAGTGTCTG AAGTTAGATT TGAGAATTTG 660
ATCAGAGAGG ACAGTAAGCA TGGATGAGGA AGTCACTGTG ACTCATGGCA GGGGAGGGTG 720
GAGGGCACCC TCTGAGGAAG ATGGAGATAT ATCCTGAAAG CCCTTCCTGC GGTCTATGAG 780
GCCGGGTGCC ATCTGCCTCC CGCCAGCCTC TCTTCCTGCG GCCCTGGTCC AGCCTCCCCA 840
CTCCAGCCCA GTGGGCCTTC TTTCAGTTCC TTGAATGCCC TGGACTTTGT TTCACCCCAG 900
GGCCCTCACA AGTGCAATTT CCTCTTCTCA GAATTTCTAA CACCCTTCAG CTTCTGCTCT 960
ACCTTCTTCC ACTCCAATCA GATCTCATTT TGAATATCAC TTCCCCAAGA AGACTTTCCC 1020
CAAATCGTCG GGCCTTAAGT CTGTGTTAGA ACCCTCTGTC AAACTTCCCC CTATTACCTA 1080
GTACTTCTTA GCATTTACCA CAATTGTAAC TCAGTATGGT GTAATGATTT GCTTATGGCC 1140
AATCTCAGTG GATAAGCTTT TTGAGGGCAG ACACCCTACC TGCCTTGTCT ATTAATACAA 1200
CTCAGTCCCT AATAGAGGAC CCACTGATGC ATTTTTACCT ACCCTTGGTC TGTGAGGATT 1260
GGAAGTGGCA CAATGCAATG TATGCGGTAT TTTGATATAA AATATTGAAC TAATATTCCA 1320
GAAATACATT TAAAATGTTA GATTAAATGT GTAAGTGAAT GTGAAGGTAA ATGGTTCACT 1380
GGATGGTGAA ACAGCTAATC TCTCAAATTA AGACTCTACA GCATATAAAT ATATAGGCTG 1440
CTGCTACCCA AAGGACAATC TCTCAGTCTC TCCCGGAGTA CCTCGCTGCC AGATCAATCT 1500
TCTTTAAACA CCATTTTTAT CACAGGACTC ATGCTTAAAA TTTTCAGAGA CTCCATTTCC 1560
CTTCCCTGCT GCAACTGAAG TCCCCCCACA GACTTGCAGT GGCCTTTAGA ATGTGTCTGG 1620
GCCCCGGCTC ACTTCTGCTC ATGGAAGGCT AGTTCTTTCA TGCTTCCATT AACCTATCGG 1680
GCTCATTTTC CCACCTCCAT GACTTGGCCC ACAGTGCCTC CCTTTCTTGG AAGGCCCTCA 1740
CCTTTCTCCA GAACACACTG GGCATTGTCC CTGTCACTTA AGACCGACCT CAACTCTCAG 1800
TTCCTCCCTG GAGCTTCAGC CTCTGGCCGT TTCTTGCCTA GTTGTTTTAG GCTCCTTTGA 1860
ATTCCTATAG CCCCAGAGAA CCACAACATA GTTCTCAATG TATACTGTCC TGGATTGTTC 1920
AGTATAGATT CTTGGGAGTT ATACACGTCT CATAATAGAT AATAAATTCC TCATCAAACC 1980
AAGGGGAACC TAAAATAATG TAGATCACCC TTGTCTTCCC 2020
|
